Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To assess the effectiveness of structured blood glucose testing in poorly controlled, noninsulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This 12-month, prospective, cluster-randomized, multicenter study recruited 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetic subjects from 34 primary care practices in the U.S. Practices were randomized to an active control group (ACG) with enhanced usual care or a structured testing group (STG) with enhanced usual care and at least quarterly use of structured self-monitoring of blood glucose (SMBG). STG patients and physicians were trained to use a paper tool to collect/interpret 7-point glucose profiles over 3 consecutive days. The primary end point was A1C level measured at 12 months. RESULTS: The 12-month intent-to-treat analysis (ACG, n = 227; STG, n = 256) showed significantly greater reductions in mean (SE) A1C in the STG compared with the ACG: −1.2% (0.09) vs. −0.9% (0.10); Δ = −0.3%; P = 0.04. Per protocol analysis (ACG, n = 161; STG, n = 130) showed even greater mean (SE) A1C reductions in the STG compared with the ACG: −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003. Significantly more STG patients received a treatment change recommendation at the month 1 visit compared with ACG patients, regardless of the patient’s initial baseline A1C level: 179 (75.5%) vs. 61 (28.0%); <0.0001. Both STG and ACG patients displayed significant (P < 0.0001) improvements in general well-being (GWB). CONCLUSIONS: Appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes without decreasing GWB.
Overview
CoChat Summary
TL;DR
In poorly controlled, insulin-naïve type 2 diabetes, structured self-monitoring of blood glucose (SMBG) plus enhanced usual care reduced A1C significantly more than enhanced usual care alone over 12 months. It also produced more timely treatment changes without decreasing general well-being.
Key findings
- In the intent-to-treat analysis (ACG n = 227; STG n = 256), mean (SE) A1C reductions were −1.2% (0.09) for STG vs. −0.9% (0.10) for ACG; Δ = −0.3%; P = 0.04. Per-protocol reductions were −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003.
- Significantly more STG patients received a treatment change recommendation at month 1: 179 (75.5%) vs. 61 (28.0%); P < 0.0001. Mean (SD) scheduled visits with a treatment change recommendation were 2.7 (1.5) vs. 1.1 (1.0); P < 0.0001. More STG patients started intermediate- or long-acting insulin: 42 vs. 23; P = 0.046.
- STG subjects showed reduced preprandial-to-postprandial glucose excursions from month 1 to month 12: breakfast 44 to 35 mg/dL (P < 0.005), lunch 25 to 17 mg/dL (P < 0.03), supper 34 to 26 mg/dL (P < 0.05). Mean amplitude of glucose excursions fell from 38.5 (0.9) to 34.3 (1.0) mg/dL (P = 0.0003).
- General well-being improved in both groups (ACG P < 0.007; STG P < 0.0001), with no significant between-group difference over time; per-protocol adherent STG subjects had greater improvement than adherent ACG subjects (P < 0.04).
Methods
- 12-month prospective, cluster-randomized, multicenter study in 34 U.S. primary care practices randomized to active control (ACG, n = 13 practices) or structured testing (STG, n = 21 practices); 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients were included in the intent-to-treat cohort (ACG n = 227; STG n = 256).
- STG patients and physicians used the Accu-Chek 360° View tool to collect/interpret 7-point glucose profiles over 3 consecutive days before scheduled visits; ACG received enhanced usual care only. Primary endpoint was A1C at 12 months.
- Linear mixed models compared groups over time, controlling for baseline A1C, age, gender, and race as fixed effects and practice site and subject as random effects; intent-to-treat and per-protocol analyses were performed.
Limitations
- Stated: no third study arm assessed the effect of increased attention in both groups; the study could not determine whether treatment changes were clinically appropriate, because it measured number rather than type of change; it could not determine how many recommended changes actually occurred; and STG had greater attrition than ACG (not statistically significant), possibly reflecting intervention burden and biasing findings.
- Evident from the text: the ACG received enhanced usual care, free meters/strips, and more frequent visits, so between-group differences may be conservative; per-protocol results depend on adherence definitions and exclusion of nonadherent STG patients, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
4 Valid · 1 Not valid · 4 Not checked · 51 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Inconsistent findings seen in studies of insulin-naïve type 2 diabetic patients may be due, in part, to differences in key design issues, such as subject selection criteria (e.g., whether or not patients had poor glycemic control at study entry), critical content differences in the actual SMBG intervention (e.g., whether physicians were privy to patient SMBG data), fidelity of treatment delivery (”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > Abstract > CONCLUSIONS
What the sources say
- Supportedcites [14] Polonsky, 2010, The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986], BMC Fam Pract source
The Background summary says that differences in SMBG protocols and study designs have left findings in insulin-naïve type 2 diabetes unclear. Its sections on baseline HbA1c, HCP use of SMBG data, and completion of the prescribed protocol address subject selection, intervention content and delivery, and adherence. Page numbers are not available in our copy. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measurements of mean amplitude of glucose excursions indicated significant (P = 0.0003) mean (SE) reductions in glycemic variability among STG subjects from 38.5 mg/dL (0.9) at month 1 to 34.3 mg/dL (1.0) at month 12.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no changes in these findings when insulin-using patients were excluded from the analyses.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PP analyses revealed that adherent STG subjects reported a significantly greater improvement in GWB than adherent ACG subjects (P < 0.04).”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > General well-being
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar between-group differences occurred using last observation carried forward analysis (last A1C before insulin start carried forward): −1.0% (0.10) vs. −0.7% (0.10); Δ = −0.3%; P = 0.03.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Changes in treatment
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 60 claims and to verify the 2 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“per protocol analysis of the STeP study showed a significant between-group difference, favoring sSMBG, for general emotional well-being (WHO-5), regimen-related diabetes distress (DDS subscale), and diabetes-specific self-efficacy (CIDS) (61, 62, 64).”
From The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis (2023) · cites this paper as [61]
Experimental — accuracy not yet measuredIn the citing paper
“In a year-long study of insulin-naive people with diabetes with suboptimal initial glycemic outcomes, a group trained in structured BGM (a paper tool was used at least quarterly to collect and interpret seven-point BGM profiles taken on three consecutive days) reduced their A1C levels by 0.3% more than the control group (32).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [32]
In the citing paper
“To optimally benefit from structured SMBG, the obtained BG values therefore have to be actively used by PwD or healthcare professionals (HCPs) for therapeutic decisions or therapy adjustments, such as changes in eating behavior, lifestyle and/or anti-diabetic therapy [9].”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [9]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015 · cited 1×
“GWBwas measured using theWHO-5 Well-Being Index assessment tool (17), a widely used, five-item questionnaire with a total score range of from 0–100 (higher scores indicatingmorepositivewell-being).”
Method(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citation6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s006 · Cited by 762
Does monitoring goal progress promote goal attainment? A meta-analysis of the experimental evidence.
Harkin, B., Webb, T. L., Chang, B. P. I., Prestwich, A., Conner, M., Kellar, I., Benn, Y., & Sheeran, P. (2016) · Psychological Bulletin · doi:10.1037/bul0000025 · Cited by 564
“…67 60 3.37***b -0.04de Phelan et al. (2014) Phone Weight, diet, PA 128 133 0.28*a 0.16d Piette et al. (2011) Diary Physical activity 145 146 -0.47***a 0.40**de Polonsky et al. (2011) SMBG BG 188 187 -0.37***a 0.33**d Polzien et al. (2007) Diary Weight, diet, PA 16 16 0.58a 0.07d Proudfoot et al.…”
InfluentialChomutare, T., Fernandez-Luque, L., Årsand, E., & Hartvigsen, G. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1874 · Cited by 451
“In contrast, Polonsky et al [28] argue that previous research has not considered structured SMBG with proper education [28,29], where participants are empowered with actionable knowledge on how to deal with different circumstances related to blood glucose variability.”
BackgroundSelf-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2012) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 250
An Effective Model of Diabetes Care and Education: The ADCES7 Self-Care Behaviors™
Association of Diabetes Care and Education Specialists, & Kolb, L. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721720978154 · Cited by 246
Freckmann, G., Schmid, C., Baumstark, A., Pleus, S., Link, M., & Haug, C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600510 · Cited by 237
A View Beyond HbA1c: Role of Continuous Glucose Monitoring
Chehregosha, H., Khamseh, M. E., Malek, M., Hosseinpanah, F., & Ismail-Beigi, F. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0619-1 · Cited by 235
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring
Edelman, S. V., Argento, N. B., Pettus, J., & Hirsch, I. B. (2018) · Diabetes Care · doi:10.2337/dc18-1150 · Cited by 199
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14528 · Cited by 197
Guideline for management of postmeal glucose in diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.08.002 · Cited by 183
An Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors ®
American Association of Diabetes Educators (2020) · The Diabetes Educator · doi:10.1177/0145721719894903 · Cited by 184
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
Insulin therapy and hypoglycemia
McCall, A. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.001 · Cited by 177
Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome
Burnett, L. C., LeDuc, C. A., Sulsona, C. R., Paull, D., Rausch, R., Eddiry, S., Carli, J. F. M., Morabito, M. V., Skowronski, A. A., Hubner, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88648 · Cited by 175
Glucose variability: An emerging target for the treatment of diabetes mellitus
Frontoni, S., Di Bartolo, P., Avogaro, A., Bosi, E., Paolisso, G., & Ceriello, A. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.007 · Cited by 174
“functional to the translation of glycemic values into pharmacological and other therapeutic actions, has significantly reduced fluctuations in daily glycemic values over a one-year timespan [92].”
BackgroundRSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
“SMBG is currently the optimal method for assessing plasma glucose levels and evidence suggests that structured SMBG followed by therapeutic interventions result in greater HbA1c reduction in individuals with T2DM compared with programs without structured SMBG.[332-334] Therefore, the panel suggest to include SMBG with…”
BackgroundMethodFarmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., et al. (2012) · BMJ · doi:10.1136/bmj.e486 · Cited by 156
Young, L. A., Buse, J. B., Weaver, M. A., Vu, M. B., Mitchell, C. M., Blakeney, T., Grimm, K., Rees, J., Niblock, F., Donahue, K. E., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1233 · Cited by 148
Yang, Y., Lee, E. Y., Kim, H.-S., Lee, S.-H., Yoon, K.-H., & Cho, J.-H. (2020) · JMIR mHealth and uHealth · doi:10.2196/16266 · Cited by 148
“Because there is evidence that supports a correlation between higher SMBG frequency and lower HbA1c [15,16], we established SMBG measurement guidelines to encourage more SMBG testing when the patient’s HbA1c level was high.”
MethodNatural Nrf2 activators in diabetes
Jiménez‐Osorio, A. S., González-Reyes, S., & Pedraza‐Chaverrí, J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.07.009 · Cited by 161
Glycaemic management in diabetes: old and new approaches
Ceriello, A., Prattichizzo, F., Phillip, M., Hirsch, I. B., Mathieu, C., & Battelino, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00245-x · Cited by 139
Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus
Chew, B. H., Vos, R. C., Metzendorf, M.-I., Scholten, R. J., & Rutten, G. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011469.pub2 · Cited by 138
Greenwood, D. A., Blozis, S. A., Young, H. M., Nesbitt, T. S., & Quinn, C. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4112 · Cited by 128
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
Bajaj, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0604-7 · Cited by 125
Bailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Goyal, S., Morita, P. P., Lewis, G., Yu, C., Seto, E., & Cafazzo, J. A. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.06.007 · Cited by 145
Ahmad, A., Rasul, T., Yousaf, A., & Zaman, U. (2020) · Journal of Open Innovation Technology Market and Complexity · doi:10.3390/joitmc6030081 · Cited by 163
“, those requiring no finger-pricking or needle insertion) for diabetic patients make self-monitoring of glucose less time-consuming and more convenient and also allow them to change the dose of insulin if required [22].”
BackgroundInterferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge
Erbach, M., Freckmann, G., Hinzmann, R., Kulzer, B., Ziegler, R., Heinemann, L., & Schnell, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816641433 · Cited by 115
Bosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & on behalf of the PRISMA Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0092 · Cited by 105
“However, recent studies utilizing SMBG as an integral component of diabetes care showed improvements in mean glucose (8–12), glycemic variability (8), metabolic risk factors (10), depression and diabetes-related distress (13), and health behaviors (10–12).”
BackgroundMobile phone health apps for diabetes management: Current evidence and future developments
Goyal, S., & Cafazzo, J. A. (2013) · QJM · doi:10.1093/qjmed/hct203 · Cited by 106
“Although the role of self-monitoring of blood glucose (SMBG) among T2DM patients on oral medications remains controversial, there is still some consensus that these patients could benefit from monitoring blood glucose when viewed in the context of their lifestyle behaviours.(7) Although there exist individual apps tha…”
BackgroundEhrhardt, N., & Al Zaghal, E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818790994 · Cited by 105
Klonoff, D. C., Blonde, L., Cembrowski, G., Chacra, A. R., Charpentier, G., Colagiuri, S., Dailey, G., Gabbay, R. A., Heinemann, L., Kerr, D., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500630 · Cited by 97
Self-citationGreenwood, D. A., Young, H. M., & Quinn, C. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813519311 · Cited by 96
Berard, L., Blumer, I. R., Houlden, R. L., Miller, D. B., & Woo, V. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.017 · Cited by 106
Mannucci, E., Antenore, A., Giorgino, F., & Scavini, M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719290 · Cited by 90
Baumstark, A., Pleus, S., Schmid, C., Link, M., Haug, C., & Freckmann, G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600511 · Cited by 90
Sendekie, A. K., Netere, A. K., Kasahun, A. E., & Belachew, E. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274971 · Cited by 149
“Therefore, patients could be encouraged to practice SBMG, share their testing results with healthcare providers, and the clinicians act towards making treatment decisions [49, 50].”
BackgroundSelf-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700225 · Cited by 88
Bergenstal, R. M., Mullen, D. M., Strock, E., Johnson, M. L., & Xi, M. X. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108106 · Cited by 87
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Axel-Schweitzer, M., Petersen, B., & Wagner, R. S. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0073 · Cited by 85
Self-citationThe Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81
Bolen, S. D., Chandar, A. K., Falck-Ytter, C., Tyler, C. V., Perzynski, A. T., Gertz, A. M., Sage, P., Lewis, S., Cobabe, M., Ye, Y., et al. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2855-4 · Cited by 96
Furler, J., O’Neal, D., Speight, J., Manski-Nankervis, J.-A., Gorelik, A., Holmes-Truscott, E., Ginnivan, L., Young, D., Best, J., dean, et al. (2017) · BMJ · doi:10.1136/bmj.j783 · Cited by 78
Kulzer, B., Daenschel, W., Daenschel, I., Schramm, W., Messinger, D., Weissmann, J., Vesper, I., Parkin, C. G., & Heinemann, L. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.09.002 · Cited by 77
Self-citationSelf-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients
Polonsky, W. H., & Fisher, L. (2013) · Diabetes Care · doi:10.2337/dc12-0731 · Cited by 77
Self-citationOrji, R., Lomotey, R., Oyibo, K., Orji, F., Blustein, J., & Shahid, S. (2018) · DIGITAL HEALTH · doi:10.1177/2055207618797554 · Cited by 79
Ceriello, A., Barkai, L., Christiansen, J. S., Czupryniak, L., Gomis, R., Harno, K., Kulzer, B., Ludvigsson, J., Némethyová, Z., Owens, D. R., et al. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.07.005 · Cited by 80
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Psychology, technology, and diabetes management.
Gonder-Frederick, L. A., Shepard, J. A., Grabman, J. H., & Ritterband, L. M. (2016) · American Psychologist · doi:10.1037/a0040383 · Cited by 74
“However, recent research suggests that structured SMBG programs with systematic guidance and feedback can improve control and well-being in these patients (Fisher et al., 2012; Polonsky et al., 2011).”
BackgroundFreckmann, G., Schmid, C., Baumstark, A., Rutschmann, M., Haug, C., & Heinemann, L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815580160 · Cited by 70
Continuous Glucose Monitoring As a Behavior Modification Tool
Ehrhardt, N., & Al Zaghal, E. (2020) · Clinical Diabetes · doi:10.2337/cd19-0037 · Cited by 69
The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes
Amod, A. (2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872276 · Cited by 73
Moon, S. J., Kim, K., Lee, W. J., Lee, M. Y., Vigersky, R., & Park, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14852 · Cited by 69
Berard, L. D., Siemens, R., & Woo, V. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.007 · Cited by 69
Brazg, R. L., Klaff, L. J., & Parkin, C. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700117 · Cited by 68
Self-citationLee, C. S., Westland, H., Faulkner, K. M., Iovino, P., Thompson, J. H., Sexton, J., Farry, E., Jaarsma, T., & Riegel, B. J. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104322 · Cited by 83
Results that matter: Structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes
Parkin, C. G., Buskirk, A., Hinnen, D. A., & Schweitzer, M. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.002 · Cited by 71
Self-citationOffringa, R., Sheng, T., Parks, L., Clements, M., Kerr, D., & Greenfield, M. S. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747291 · Cited by 66
Effective Strategies for Behavior Change
Coleman, M. T., & Pasternak, R. H. (2012) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2012.03.004 · Cited by 76
Use of Mobile Health Technology in the Prevention and Management of Diabetes Mellitus
Hartz, J., Yingling, L., & Powell-Wiley, T. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0796-8 · Cited by 64
Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach
Adolfsson, P., Parkin, C. G., Thomas, A., & Krinelke, L. G. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.1.24 · Cited by 63
Self-citationPleus, S., Baumstark, A., Jendrike, N., Mende, J., Link, M., Zschornack, E., Haug, C., & Freckmann, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001067 · Cited by 63
Kim, E. K., Kwak, S. H., Jung, H. S., Koo, B. K., Moon, M. K., Lim, S., Jang, H. C., Park, K. S., & Cho, Y. M. (2019) · Diabetes Care · doi:10.2337/dc17-2197 · Cited by 61
Lee, J. Y., Chan, C. K. Y., Chua, S. S., Paraidathathu, T., Lee, K. K.-C., Tan, C. S. S., Nasir, N., & Lee, S. W. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026575 · Cited by 60
Wambui Charity, K., Kumar, A. M. V., Hinderaker, S. G., Chinnakali, P., Pastakia, S. D., & Kamano, J. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.006 · Cited by 60
“The study from Central Texas reported similar findings that fewer environmental barriers including costs were significantly associated with good adherence.”
BackgroundResultInfluentialThe 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised)
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872287 · Cited by 69
Adachi, M., Yamaoka, K., Watanabe, M., Nishikawa, M., Kobayashi, I., Hida, E., & Tango, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-467 · Cited by 57
Pleus, S., Freckmann, G., Schauer, S., Heinemann, L., Ziegler, R., Ji, L., Mohan, V., Calliari, L. E., & Hinzmann, R. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01254-8 · Cited by 55
Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30385-7 · Cited by 55
Perrin, N., Bodicoat, D. H., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.04.001 · Cited by 53
Cersosimo, E., Johnson, E. L., Chovanes, C., & Skolnik, N. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13108 · Cited by 52
Amante, D. J., Harlan, D. M., Lemon, S. C., McManus, D. D., Olaitan, O. O., Pagoto, S. L., Gerber, B. S., & Thompson, M. J. (2021) · JMIR Diabetes · doi:10.2196/25574 · Cited by 44
Pimazoni-Netto, A., Rodbard, D., & Zanella on behalf of the Diabetes E, M. T. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0054 · Cited by 50
Hinzmann, R., Schlaeger, C., & Tran, C. T. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4520 · Cited by 62
Melmer, A., & Laimer, M. W. (2016) · Endocrine development · doi:10.1159/000439364 · Cited by 58
Fisher, L., Polonsky, W., Parkin, C. G., Jelsovsky, Z., Amstutz, L., & Wagner, R. S. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.619176 · Cited by 47
Self-citationSchnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0028 · Cited by 47
Polonsky, W. H., Layne, J. E., Parkin, C. G., Kusiak, C. M., Barleen, N. A., Miller, D. P., Zisser, H., & Dixon, R. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0105 · Cited by 46
Self-citationPolonsky, W. H., & Fisher, L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0620-7 · Cited by 49
Self-citationFisher, L., Polonsky, W. H., Parkin, C. G., Jelsovsky, Z., Petersen, B., & Wagner, R. S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.016 · Cited by 44
Self-citationRosenstock, J., Franco, D., Korpachev, V., Shumel, B., Ma, Y., Baughman, R., Amin, N., McGill, J. B., & for the Affinity 2 Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0629 · Cited by 43
Konnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A., Hillmer, M., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 37
Ji, L., Su, Q., Feng, B., Shan, Z., Hu, R., Xing, X., & Xue, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.08.005 · Cited by 43
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 57
Parsons, S. N., Luzio, S. D., Harvey, J. N., Bain, S. C., Cheung, W. Y., Watkins, A., & Owens, D. R. (2019) · Diabetic Medicine · doi:10.1111/dme.13899 · Cited by 39
Tanenbaum, M. L., Leventhal, H., Breland, J. Y., Yu, J., Walker, E. A., & Gonzalez, J. S. (2015) · Diabetic Medicine · doi:10.1111/dme.12745 · Cited by 42
Metadata
- Authors
- Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S.
- Affiliations
- University of California San Diego (US)
- University of California, San Francisco (US)
- Endeavor Health (US)
- Mid America Diabetes Associates, Wichita, Kansas
- Health Management Resources, Carmel, Indiana
- Biostat International, Tampa, Florida
- Roche Diagnostics, Indianapolis, Indiana
- Corresponding author
- Parkin, Christopher G.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 262-267
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024331
- OpenAlex
- W2102487069
- Semantic Scholar
- 074343a0d8101d85936aedd3d5e7285d19afe6d6
- Cited by
- 429
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 28 · 2017: 25 · 2016: 47 · 2015: 37 · 2014: 31 · 2013: 44 · 2012: 43
- FWCI
- 37.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, glycemic control, HbA1c, insulin-naive patients, glycemic variability, treatment intensification, general well-being, primary care
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Participation, Primary Health Care, Prospective Studies, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.